Regarding the clinical site of myelopathy, 18 (58%) patients had diffuse myelopathy involving most of the spinal cord segments, mainly attributed to patients with hereditary degenerative ataxias; 9 (29%) patients had dorsal myelopathy mainly related to ATM and MS. This evidence concerns the gene ATM and myeloid sarcoma.